BioKDE

Clinical Trial
Meta-Analysis
Randomized Controlled Trial
Review
Systematic Review

1 year

5 year

10 year

Start Date:

End Date:

2,647,852 results (0.775 seconds)

Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover.
Caroline Wilson, Fatma Gossiel, +4 authors, Robert E Coleman.
J Bone Oncol. 2016 Feb 11; 5(1):43-9. PMID: 26998426 Free PMC article

Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.
Bernd Gerber, Gunter von Minckwitz, +12 authors, German Breast Group Investigators.
J Clin Oncol. 2011 May 02; 29(17):2334-41. PMID: 21537042

Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model.
Chiaming Fan, Kristen R Georgiou, +4 authors, Cory J Xian.
Breast Cancer Res Treat. 2017 May 26; 165(1):41-51. PMID: 28550626

Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure.
Thomas Delate, Erin J Aiello Bowles, +11 authors, Edward Wagner.
Cancer Epidemiol Biomarkers Prev. 2012 Feb 15; 21(4):673-80. PMID: 22337532 Free PMC article

[Association between cancer related fatigue and social support in patients after breast cancer chemotherapy in Changsha].
Pinglan Jiang, Shuhong Wang, +3 authors, Juan Lai.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Sep 29; 36(9):844-8. PMID: 21946202

Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
Irene Catucci, Ana Osorio, +25 authors, Paolo Peterlongo.
Genet Med. 2017 Aug 24; 20(4):452-457. PMID: 28837162

[Analysis of the Risk Factors of Febrile Neutropenia Among 72 Women Receiving FEC in Early Breast Cancer Chemotherapy].
Natsumi Ishii, Toshihiko Fujimori, Takahiro Kasagawa, Ikuo Udagawa.
Gan To Kagaku Ryoho. 2017 Jan 31; 43(12):1555-1557. PMID: 28133055

A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens.
Sarah J Zardawi, Ina Nordman, Nicholas Zdenkowski.
Cancer Rep (Hoboken). 2020 Aug 06; 3(5):e1266. PMID: 32761893 Free PMC article

Longitudinal Trends in Anxiety, Depression, and Quality of Life During Different Intermittent Periods of Adjuvant Breast Cancer Chemotherapy.
Jiayuan Zhang, Yuqiu Zhou, +2 authors, Guangchun Zeng.
Cancer Nurs. 2016 Dec 07; 41(1):62-68. PMID: 27922916

Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy.
K S Courneya, D C McKenzie, +10 authors, R J Segal.
Br J Cancer. 2014 Aug 21; 111(9):1718-25. PMID: 25144625 Free PMC article

Survey about the use of scalp cooling to prevent alopecia during breast cancer chemotherapy treatment in Canada.
Julie Lemieux, Louise Provencher, Christian Laflamme.
Can Oncol Nurs J. 2014 Jun 07; 24(2):102-8. PMID: 24902427

Inhibition of Cytochrome P450 Enzyme and Drug-Drug Interaction Potential of Acid Reducing Agents Used in Management of CDK Inhibitors for Breast Cancer Chemotherapy.
Prajakta Harish Patil, Puralae Channabasavaiah Jagadish, +7 authors, Jakir Pinjari.
Curr Drug Metab. 2022 Feb 22; 23(2):137-149. PMID: 35184709

A Case Report of Sanguis Draconis for Treating a Patient With Refractory Wound Dehiscence After Breast Cancer Chemotherapy.
Guizhen Zhang, Yafang Hua, Xueqin Jin, Chunmei Yan.
Holist Nurs Pract. 2015 Dec 04; 30(1):10-3. PMID: 26633721

Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.
Harold J Burstein, Leroy M Parker, +13 authors, Eric P Winer.
J Clin Oncol. 2005 Nov 19; 23(33):8340-7. PMID: 16293865

Role of Kinematics Assessment and Multimodal Sensorimotor Training for Motion Deficits in Breast Cancer Chemotherapy-Induced Polyneuropathy: A Perspective on Virtual Reality Avatars.
Cristian Axenie, Daria Kurz.
Front Oncol. 2020 Aug 12; 10:1419. PMID: 32903366 Free PMC article

Novel selenylated imidazo[1,2-a]pyridines for breast cancer chemotherapy: Inhibition of cell proliferation by Akt-mediated regulation, DNA cleavage and apoptosis.
Gabriela M Almeida, Jamal Rafique, +6 authors, Fabiana Ourique.
Biochem Biophys Res Commun. 2018 Jul 14; 503(3):1291-1297. PMID: 30017191

[Equalization of breast cancer chemotherapy at general hospital( II )-evaluation of safety in FEC and TC regimens].
Noriaki Kitada, Masayuki Nishino, +7 authors, Masakatsu Watari.
Gan To Kagaku Ryoho. 2009 Oct 20; 36(10):1671-5. PMID: 19838026

Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in Taiwan.
Ya-Chen Tina Shih, I-Wen Pan, Yi-Wen Tsai.
Pharmacoeconomics. 2009 Nov 06; 27(11):947-61. PMID: 19888794

Curcumin Ameliorates Cisplatin-Induced Nephrotoxicity and Potentiates Its Anticancer Activity in SD Rats: Potential Role of Curcumin in Breast Cancer Chemotherapy.
Parveen Kumar, Chandana C Barua, Kunjbihari Sulakhiya, Rajeev Kumar Sharma.
Front Pharmacol. 2017 Apr 04; 8:132. PMID: 28420987 Free PMC article

Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study.
Rocío A López Zunini, Carole Scherling, +4 authors, Andra M Smith.
Brain Imaging Behav. 2012 Dec 18; 7(4):460-77. PMID: 23242968

Previous

Next